Nordix Dna ApS
Private limited companyCVR 36908130FrederikshavnActive
Nordix Dna ApS is a private limited company, based in Frederikshavn, active in wholesale of medical and hospital supplies, founded in 2015. Equity was negative at the end of 2025 (−DKK 1,465). The company made a loss in both 2024 and 2025, most recently DKK 9,011.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 98,799 to DKK 9,011 (2024 → 2025).
- Equity turned negative: −DKK 1,465 (2024 → 2025).
Employees
- 3 fewer employees than a year earlier: 2 (04/2023) against 5 (04/2022).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | −4 | 218 | 755 | 690 | −52 | −9 | +82.8% |
| Operating profit (EBIT) | −4 | 14 | 98 | 8 | −97 | −9 | +90.7% |
| Profit before tax | −7 | 14 | 95 | 8 | −99 | −9 | +90.9% |
| Net profit | −7 | 14 | 74 | 8 | −99 | −9 | +90.9% |
| Total assets | 40 | 198 | 1,568 | 669 | 98 | 98 | 0% |
| Equity | −14 | 40 | 114 | 106 | 8 | −1 | −119.4% |
| Liabilities | 54 | 158 | 1,455 | 563 | 91 | 100 | +9.9% |
| Cash and cash equivalents | 0 | 185 | 1,555 | 10 | 0 | – | – |
| Average number of employees | 1 | 1 | 2 | 2 | 1 | – | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 1,465 at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 2 years in a row
Net result has been negative in 2024–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/10/2024 – 30/09/2025 | 16/04/2026 | The company | PDF not statedXBRL |
| 2024 | 01/10/2023 – 30/09/2024 | 16/04/2025 | The company | PDF not statedXBRL |
| 2023 | 01/10/2022 – 30/09/2023 | 13/08/2024 | The company | PDF not statedXBRL |
| 2022 | 01/10/2021 – 30/09/2022 | 02/05/2023 | The company | PDF not statedXBRL |
| 2021 | 01/10/2020 – 30/09/2021 | 01/04/2022 | The company | PDF not statedXBRL |
| 2020 | 01/10/2019 – 30/09/2020 | 31/03/2021 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
187 companies in the databaseComparison with the other companies in wholesale of medical and hospital supplies based on the latest financial year.
Industry median: gross profit DKK 5.8m, net profit DKK 1.2m, equity DKK 5.4m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 63,523of 69,742 Better than 9% | No. 60,020of 69,964 Better than 14% |
| Same industry and fewer than 20 employees139 companies in the comparison | No. 134of 139 Better than 4% | No. 129of 139 Better than 7% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 31,352of 33,588 Better than 7% | No. 28,348of 33,687 Better than 16% |
| All companies of type ApS66,508 companies in the comparison | No. 61,060of 66,379 Better than 8% | No. 56,325of 66,505 Better than 15% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of medical and hospital supplies- Nordix Dna ApS−DKK 9,011
- Orifarm Generics A/SDKK 399.8m
- 3shape Trios A/SDKK 203.5m
- Nordix Dna ApS−DKK 9,011
- Orifarm Generics A/SDKK 77.2m
- 3shape Trios A/SDKK 58.4m
- Nordix Dna ApS−DKK 1,465
- Orifarm Generics A/SDKK 496.3m
- 3shape Trios A/SDKK 121.7m
- Nordix Dna ApS2
- Orifarm Generics A/S255
- 3shape Trios A/S56
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Nordix Holding ApS100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Casper Holm Mulberg | Director | 08/07/2024 |
- Founders
- Tommy Walther Larsson
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Tommy Walther Larsson | Director | 16/05/2015 | 31/03/2020 |
| Casper Holm Mulberg | Director | 31/03/2020 | 07/05/2024 |
Signing rule: Virksomheden tegnes af direktionen
Address and production units
1 active production unitsÅhaven 13
9900 Frederikshavn
| Production unit | Address | Employees | P number |
|---|---|---|---|
| NORDIX DNA ApS | Åhaven 13, 9900 Frederikshavn | 2 | 1020441727 |
Purpose
Virksomhedens formål er at virke som handelselskab med køb og salg, samt anden beslægtet virksomhed efter direktionens skøn.
The purpose is quoted from the register in Danish.
Changes year by year
24 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20251 changeaccounts 1
- AccountsAnnual report for 2024 published
20245 changesaccounts 1 · status 2 · management 2
- AccountsAnnual report for 2023 published
- StatusStatus changed to active
- ManagementCasper Holm Mulberg appointed director
- StatusStatus changed to under compulsory dissolution
- ManagementCasper Holm Mulberg stepped down as director
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20214 changesname 1 · capital 1 · accounts 1 · address 1
- NameName changed from NORDIX DNA IVS to NORDIX DNA ApS
- CapitalShare capital changed from 1 DKK to 40,000 DKK
- AccountsAnnual report for 2020 published
- AddressMoved to Åhaven 13, 9900 Frederikshavn
20208 changesaddress 2 · name 1 · industry 1 · management 2 · ownership 2
- AddressMoved to Toftegårdsvej 32A, 9900 Frederikshavn
- AddressMoved to Sdr. Ringvej 36, 9300 Sæby
- NameName changed from FAB.DK IVS to NORDIX DNA IVS
- IndustryIndustry changed to Wholesale of medical and hospital supplies (464620)
- ManagementCasper Holm Mulberg appointed director
- ManagementTommy Walther Larsson stepped down as director
- OwnershipNORDIX HOLDING ApS registered as owner (100%)
- OwnershipTommy Walther Larsson is no longer registered as owner
20153 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as FAB.DK IVS
- ManagementTommy Walther Larsson appointed director
- OwnershipTommy Walther Larsson registered as owner (100%)
Related companies
Largest in the industry
- Orifarm Generics A/SDKK 399.8m
- 3shape Trios A/SDKK 203.5m
- Medtronic Danmark A/SDKK 177.9m
- Plandent A/SDKK 172m
- Alcon Nordic A/SDKK 161m
- Siemens Healthcare A/SDKK 154.9m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.